The rare skin disease called melanoma has emerged as a major health issue in India, with some doctors warning that it could leave millions of Indians with little hope of survival.
More than 2,000 people are currently living with the cancer, with around 50,000 dying from it each year, according to a new study.
The research, published by the American Journal of Human Genetics, shows that melanoma patients are significantly more likely to have other health conditions, including hypertension and diabetes, compared to those who are not.
Melanoma patients tend to have larger tumors in the body, and more severe side effects, said Dr. Gautam Mukherjee, director of the Division of Cellular and Molecular Pathology at the Indian Institute of Medical Sciences.
Melanomas are generally found in people over 40, but there is evidence that older people have the disease more often than younger ones.
Melania Trump is the first First Lady to be diagnosed with melanoma.
The new study, published in the American Medical Association journal The Lancet, looked at the genes of about 6,000 melanoma survivors from three countries: the United States, India and Japan.
Melancholy symptoms are the most common side effects of melanoma, according the authors.
They said they found that about 80% of the patients had at least one other medical condition, and nearly one in four had hypertension, diabetes and depression.
More: India has about 2 million people with melanomas, and in some cases, the disease is so advanced that it can lead to death.
The authors said there are no known treatments for the disease.
India has more melanoma deaths than any other country, with over 1,000 in 2016, and the number of cases has risen by almost 50% since 2012.
There are currently no treatments for melanoma in India.
Melon cancer is extremely aggressive and aggressive tumors grow rapidly, and often lead to a massive loss of skin.
There are also signs that melanomas can grow inside the body.
Melanie M. Krasnick, a professor of pathology at the University of Michigan School of Medicine, said the findings are “very concerning” because they suggest that there are “significant disparities” between melanoma survival rates in India and the U.S.
In India, melanoma rates are higher than in the U: One in three Indians with melanomavirus (MV) are diagnosed and treated for the condition, compared with one in five Americans.
India also has higher rates of type 2 diabetes, hypertension and obesity.
“These are very worrisome findings because the rate of melanomas in India is higher than that in the United Kingdom, where the incidence is much lower,” Dr. Krakow said.
The study authors said they believe the higher mortality rates might be because people in India are more likely than in other countries to be living in poverty, and that there is an underdiagnosis of melanomovirus in the Indian population.
The authors added that it is difficult to know how much of this difference is genetic and how much is due to socio-economic factors.
Melanosome, or the part of the DNA responsible for the cell’s structure, can have mutations that make it difficult to detect in a lab, and can be a cause of cancer.
The mutations are usually found only in a few people.
In addition to the gene mutation, there are also genetic variants in the DNA that are known to be linked to melanomas.
Melansoma has been identified in a handful of people, but it has not been found in humans.
Experts say it is still not clear why the mutations occur.
The researchers said there was evidence that people who have the mutations may be more prone to developing other cancers, but the exact mechanism is not clear.
Researchers are still studying whether other mutations may contribute to the higher rate of cases in India compared to the United, Japan and other countries.
The study was led by Dr. Srinivasa Ranganath, associate professor of pathology at St. Louis University Medical Center.